Fig. 2From: Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysisProbabilistic sensitivity analysis. Cost-effectiveness acceptability curves showing the likelihood each strategy will be favored over ranges of willingness to pay (or acceptability) thresholds when all parameters are varied simultaneously over distributions: a third-party payer perspective, b societal perspectiveBack to article page